But other research links prisons themselves to mental health challenges and infectious disease outbreaks.
June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.
Two models, one from Washington State and another from Los Angeles County, can be duplicated elsewhere to get people into care, experts say.
Sixteen years after the success of Project START for HIV risk reduction, we still don't know what works best for helping people with HIV stay in care after prison.
Curt G. Beckwith, M.D., and Sugi Min, his mentee, discuss their clinical research focused on improving the diagnosis, treatment, and longitudinal care of HIV infection among substance users, particularly those in the criminal justice system.
A presentation at the recent conference of the Association of Nurses in AIDS Care (ANAC 2018) looked at the use of video consultations and remote diagnostics in prisons to deliver high-quality health care.
It is estimated that one-third of Americans with hepatitis C pass through the criminal justice system each year.
Post-incarceration HIV outcomes worse among women; no drug resistance despite apparent PrEP failure; cost-efficacy of adherence self-management; additional cancers in HIV-positive cancer survivors.
HIV-positive donor, HIV-negative recipient; continuum of care after incarceration in U.S.; reduced bone mineral density among men with HIV under 50; discouraging anti-inflammatory findings for an antiplatelet agent.
To Understand Challenges Black Men With HIV Face on Re-Entry From Prisons, an Intersectional Approach Is Needed, Study Shows
There are multiple reasons why re-entry into communities from prison for black men with HIV is a difficult proposition, according to a recent study.